Logo image of EMN

EASTMAN CHEMICAL CO (EMN) Stock Fundamental Analysis

NYSE:EMN - New York Stock Exchange, Inc. - US2774321002 - Common Stock - Currency: USD

91.76  -0.94 (-1.01%)

Fundamental Rating

5

EMN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. EMN has only an average score on both its financial health and profitability. EMN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. EMN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

EMN had positive earnings in the past year.
EMN had a positive operating cash flow in the past year.
Each year in the past 5 years EMN has been profitable.
EMN had a positive operating cash flow in each of the past 5 years.
EMN Yearly Net Income VS EBIT VS OCF VS FCFEMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

1.2 Ratios

With an excellent Return On Assets value of 5.88%, EMN belongs to the best of the industry, outperforming 81.71% of the companies in the same industry.
The Return On Equity of EMN (15.65%) is better than 82.93% of its industry peers.
EMN's Return On Invested Capital of 7.46% is fine compared to the rest of the industry. EMN outperforms 73.17% of its industry peers.
EMN had an Average Return On Invested Capital over the past 3 years of 9.38%. This is above the industry average of 6.57%.
Industry RankSector Rank
ROA 5.88%
ROE 15.65%
ROIC 7.46%
ROA(3y)5.68%
ROA(5y)4.95%
ROE(3y)15.6%
ROE(5y)13.49%
ROIC(3y)9.38%
ROIC(5y)8.16%
EMN Yearly ROA, ROE, ROICEMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

The Profit Margin of EMN (9.47%) is better than 81.71% of its industry peers.
EMN's Profit Margin has declined in the last couple of years.
EMN has a Operating Margin of 12.15%. This is in the better half of the industry: EMN outperforms 68.29% of its industry peers.
In the last couple of years the Operating Margin of EMN has declined.
With a Gross Margin value of 23.54%, EMN perfoms like the industry average, outperforming 43.90% of the companies in the same industry.
In the last couple of years the Gross Margin of EMN has declined.
Industry RankSector Rank
OM 12.15%
PM (TTM) 9.47%
GM 23.54%
OM growth 3Y-0.89%
OM growth 5Y-6.24%
PM growth 3Y19.83%
PM growth 5Y-1.82%
GM growth 3Y-1.35%
GM growth 5Y-1.73%
EMN Yearly Profit, Operating, Gross MarginsEMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EMN is still creating some value.
Compared to 1 year ago, EMN has less shares outstanding
The number of shares outstanding for EMN has been reduced compared to 5 years ago.
EMN has a better debt/assets ratio than last year.
EMN Yearly Shares OutstandingEMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M
EMN Yearly Total Debt VS Total AssetsEMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.57 indicates that EMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
EMN has a Altman-Z score of 2.57. This is in the better half of the industry: EMN outperforms 73.17% of its industry peers.
The Debt to FCF ratio of EMN is 8.37, which is on the high side as it means it would take EMN, 8.37 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EMN (8.37) is comparable to the rest of the industry.
EMN has a Debt/Equity ratio of 0.81. This is a neutral value indicating EMN is somewhat dependend on debt financing.
EMN's Debt to Equity ratio of 0.81 is in line compared to the rest of the industry. EMN outperforms 40.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 8.37
Altman-Z 2.57
ROIC/WACC0.91
WACC8.23%
EMN Yearly LT Debt VS Equity VS FCFEMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.3 Liquidity

EMN has a Current Ratio of 1.52. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.52, EMN is doing worse than 68.29% of the companies in the same industry.
EMN has a Quick Ratio of 1.52. This is a bad value and indicates that EMN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.78, EMN is doing worse than 85.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 0.78
EMN Yearly Current Assets VS Current LiabilitesEMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

4

3. Growth

3.1 Past

EMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.58%, which is quite impressive.
Measured over the past years, EMN shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.79% on average per year.
Looking at the last year, EMN shows a decrease in Revenue. The Revenue has decreased by -0.34% in the last year.
The Revenue has been decreasing by -1.93% on average over the past years.
EPS 1Y (TTM)22.58%
EPS 3Y1.39%
EPS 5Y-4.79%
EPS Q2Q%53.74%
Revenue 1Y (TTM)-0.34%
Revenue growth 3Y2.82%
Revenue growth 5Y-1.93%
Sales Q2Q%8.69%

3.2 Future

EMN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.11% yearly.
EMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.71% yearly.
EPS Next Y20.44%
EPS Next 2Y17.06%
EPS Next 3Y15.6%
EPS Next 5Y12.11%
Revenue Next Year2.15%
Revenue Next 2Y2.92%
Revenue Next 3Y3.47%
Revenue Next 5Y1.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EMN Yearly Revenue VS EstimatesEMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
EMN Yearly EPS VS EstimatesEMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.52 indicates a correct valuation of EMN.
84.15% of the companies in the same industry are more expensive than EMN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.28. EMN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 10.46, the valuation of EMN can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EMN indicates a rather cheap valuation: EMN is cheaper than 84.15% of the companies listed in the same industry.
EMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 91.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.52
Fwd PE 10.46
EMN Price Earnings VS Forward Price EarningsEMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EMN is valued a bit cheaper than 65.85% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMN indicates a somewhat cheap valuation: EMN is cheaper than 65.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.61
EV/EBITDA 9.29
EMN Per share dataEMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EMN has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as EMN's earnings are expected to grow with 15.60% in the coming years.
PEG (NY)0.61
PEG (5Y)N/A
EPS Next 2Y17.06%
EPS Next 3Y15.6%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.56%, EMN has a reasonable but not impressive dividend return.
EMN's Dividend Yield is rather good when compared to the industry average which is at 3.21. EMN pays more dividend than 82.93% of the companies in the same industry.
EMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 3.56%

5.2 History

The dividend of EMN is nicely growing with an annual growth rate of 7.23%!
EMN has been paying a dividend for at least 10 years, so it has a reliable track record.
EMN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)7.23%
Div Incr Years14
Div Non Decr Years29
EMN Yearly Dividends per shareEMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

5.3 Sustainability

42.82% of the earnings are spent on dividend by EMN. This is a bit on the high side, but may be sustainable.
EMN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP42.82%
EPS Next 2Y17.06%
EPS Next 3Y15.6%
EMN Yearly Income VS Free CF VS DividendEMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B
EMN Dividend Payout.EMN Dividend Payout, showing the Payout Ratio.EMN Dividend Payout.PayoutRetained Earnings

EASTMAN CHEMICAL CO

NYSE:EMN (1/30/2025, 12:03:48 PM)

91.76

-0.94 (-1.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)01-30 2025-01-30/amc
Inst Owners88.52%
Inst Owner Change-1.05%
Ins Owners0.71%
Ins Owner Change-0.19%
Market Cap10.64B
Analysts71.67
Price Target117.87 (28.45%)
Short Float %2.44%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 3.56%
Yearly Dividend3.19
Dividend Growth(5Y)7.23%
DP42.82%
Div Incr Years14
Div Non Decr Years29
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.1%
Min EPS beat(2)4.42%
Max EPS beat(2)5.79%
EPS beat(4)4
Avg EPS beat(4)5.34%
Min EPS beat(4)0.05%
Max EPS beat(4)11.11%
EPS beat(8)7
Avg EPS beat(8)2.93%
EPS beat(12)9
Avg EPS beat(12)1.78%
EPS beat(16)12
Avg EPS beat(16)2.47%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-0.76%
Max Revenue beat(2)2.62%
Revenue beat(4)1
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-1.03%
Max Revenue beat(4)2.62%
Revenue beat(8)1
Avg Revenue beat(8)-2.51%
Revenue beat(12)4
Avg Revenue beat(12)0.23%
Revenue beat(16)8
Avg Revenue beat(16)1.15%
PT rev (1m)-0.1%
PT rev (3m)0.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-16.16%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.49%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE 12.52
Fwd PE 10.46
P/S 1.14
P/FCF 17.61
P/OCF 8.87
P/B 1.88
P/tB 11.47
EV/EBITDA 9.29
EPS(TTM)7.33
EY7.99%
EPS(NY)8.77
Fwd EY9.56%
FCF(TTM)5.21
FCFY5.68%
OCF(TTM)10.34
OCFY11.27%
SpS80.61
BVpS48.78
TBVpS8
PEG (NY)0.61
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.88%
ROE 15.65%
ROCE 9.1%
ROIC 7.46%
ROICexc 7.85%
ROICexgc 13.06%
OM 12.15%
PM (TTM) 9.47%
GM 23.54%
FCFM 6.46%
ROA(3y)5.68%
ROA(5y)4.95%
ROE(3y)15.6%
ROE(5y)13.49%
ROIC(3y)9.38%
ROIC(5y)8.16%
ROICexc(3y)9.78%
ROICexc(5y)8.47%
ROICexgc(3y)17.01%
ROICexgc(5y)15%
ROCE(3y)11.44%
ROCE(5y)9.99%
ROICexcg growth 3Y4.61%
ROICexcg growth 5Y-6%
ROICexc growth 3Y7.55%
ROICexc growth 5Y-4.15%
OM growth 3Y-0.89%
OM growth 5Y-6.24%
PM growth 3Y19.83%
PM growth 5Y-1.82%
GM growth 3Y-1.35%
GM growth 5Y-1.73%
F-Score8
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.81
Debt/FCF 8.37
Debt/EBITDA 2.82
Cap/Depr 119.48%
Cap/Sales 6.37%
Interest Coverage 250
Cash Conversion 73.42%
Profit Quality 68.25%
Current Ratio 1.52
Quick Ratio 0.78
Altman-Z 2.57
F-Score8
WACC8.23%
ROIC/WACC0.91
Cap/Depr(3y)133.41%
Cap/Depr(5y)107.31%
Cap/Sales(3y)6.73%
Cap/Sales(5y)5.86%
Profit Quality(3y)76.5%
Profit Quality(5y)119.18%
High Growth Momentum
Growth
EPS 1Y (TTM)22.58%
EPS 3Y1.39%
EPS 5Y-4.79%
EPS Q2Q%53.74%
EPS Next Y20.44%
EPS Next 2Y17.06%
EPS Next 3Y15.6%
EPS Next 5Y12.11%
Revenue 1Y (TTM)-0.34%
Revenue growth 3Y2.82%
Revenue growth 5Y-1.93%
Sales Q2Q%8.69%
Revenue Next Year2.15%
Revenue Next 2Y2.92%
Revenue Next 3Y3.47%
Revenue Next 5Y1.71%
EBIT growth 1Y11.93%
EBIT growth 3Y1.91%
EBIT growth 5Y-8.05%
EBIT Next Year60.05%
EBIT Next 3Y22.92%
EBIT Next 5Y15.43%
FCF growth 1Y96.1%
FCF growth 3Y-20.14%
FCF growth 5Y-11.66%
OCF growth 1Y26.48%
OCF growth 3Y-1.89%
OCF growth 5Y-2.29%